| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00018-017-2513-1 |
| P698 | PubMed publication ID | 28389721 |
| P50 | author | Yong-Jing Gao | Q42386001 |
| P2093 | author name string | Zhi-Jun Zhang | |
| Bao-Chun Jiang | |||
| P2860 | cites work | The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion | Q24300435 |
| Chemokines and the pathophysiology of neuropathic pain | Q24683873 | ||
| Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion | Q27863414 | ||
| A chemokine-driven positive feedback loop organizes lymphoid follicles | Q28142202 | ||
| Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1) | Q28211911 | ||
| Emerging targets in neuroinflammation-driven chronic pain | Q28242435 | ||
| A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 | Q28263524 | ||
| Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo | Q28263920 | ||
| Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 | Q28505948 | ||
| Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion | Q28567269 | ||
| Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses | Q28571811 | ||
| Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain | Q28572461 | ||
| Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats | Q28577588 | ||
| Cloning and functional expression of mCCR2, a murine receptor for the C-C chemokines JE and FIC | Q28592479 | ||
| BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain | Q29616106 | ||
| The many roles of chemokines and chemokine receptors in inflammation | Q29618880 | ||
| The biology of chemokines and their receptors | Q29619170 | ||
| Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain | Q30500291 | ||
| Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions | Q42466912 | ||
| The effects of the selective and non-peptide CXCR2 receptor antagonist SB225002 on acute and long-lasting models of nociception in mice. | Q42614087 | ||
| Neutrophils recruited by CXCR1/2 signalling mediate post-incisional pain | Q43473377 | ||
| Cathepsin S generates soluble CX3CL1 (fractalkine) in vascular smooth muscle cells | Q43491560 | ||
| A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel | Q43814061 | ||
| Role of spinal CXCL1 (GROα) in opioid tolerance: a human-to-rodent translational study. | Q44348120 | ||
| CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. | Q31920342 | ||
| A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. | Q33510083 | ||
| Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning | Q33547897 | ||
| Chemokine and chemokine receptor expression in the central nervous system | Q33586743 | ||
| Neuropathic pain: aetiology, symptoms, mechanisms, and management | Q33661273 | ||
| Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE. | Q33735496 | ||
| Pain regulation by non-neuronal cells and inflammation | Q33846188 | ||
| Spared nerve injury: an animal model of persistent peripheral neuropathic pain | Q33912252 | ||
| Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice | Q33937485 | ||
| Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain | Q34132344 | ||
| Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. | Q34173693 | ||
| Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation. | Q34228079 | ||
| An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat | Q34239178 | ||
| Central sensitization and LTP: do pain and memory share similar mechanisms? | Q34277624 | ||
| Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2. | Q34325096 | ||
| Microarray analysis of rat sensory ganglia after local inflammation implicates novel cytokines in pain | Q34345165 | ||
| A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. | Q34554719 | ||
| Neuropathic pain: a clinical perspective | Q34995660 | ||
| The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system | Q35104199 | ||
| Central administration of C-X-C chemokine receptor type 4 antagonist alleviates the development and maintenance of peripheral neuropathic pain in mice | Q35224084 | ||
| Involvement of CX3CL1/CX3CR1 signaling in spinal long term potentiation | Q35576920 | ||
| Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. | Q35769711 | ||
| In vivo structure/function and expression analysis of the CX3C chemokine fractalkine | Q35865080 | ||
| Cell signaling and the genesis of neuropathic pain | Q35904210 | ||
| Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain | Q36082738 | ||
| Chemokines, chemokine receptors and pain | Q36229171 | ||
| The expression and function of chemokines involved in CNS inflammation | Q36323788 | ||
| Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons | Q36344420 | ||
| Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells | Q36368917 | ||
| Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? | Q36490874 | ||
| CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5. | Q36515088 | ||
| Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? | Q36963161 | ||
| The neuropathic pain triad: neurons, immune cells and glia | Q36983677 | ||
| Fractalkine mediates inflammatory pain through activation of satellite glial cells | Q36991021 | ||
| Focal Lysolecithin-Induced Demyelination of Peripheral Afferents Results in Neuropathic Pain Behavior That Is Attenuated by Cannabinoids | Q44418979 | ||
| p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. | Q44451943 | ||
| Neuronal injury induces cytokine-induced neutrophil chemoattractant-1 (CINC-1) production in astrocytes | Q46175730 | ||
| ATP induces long-term potentiation of C-fiber-evoked field potentials in spinal dorsal horn: the roles of P2X4 receptors and p38 MAPK in microglia. | Q46330452 | ||
| Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation | Q46442849 | ||
| Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones | Q46692808 | ||
| Spatiotemporal CCR1, CCL3(MIP-1α), CXCR4, CXCL12(SDF-1α) expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain | Q46767997 | ||
| Crucial role of neutrophils in the development of mechanical inflammatory hypernociception | Q46802148 | ||
| An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine | Q46832694 | ||
| Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain | Q47599610 | ||
| Up-regulation of CXCL1 and CXCR2 contributes to remifentanil-induced hypernociception via modulating spinal NMDA receptor expression and phosphorylation in rats | Q47608522 | ||
| Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain | Q47891712 | ||
| Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain | Q48187325 | ||
| A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia | Q48187576 | ||
| Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. | Q48215354 | ||
| Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. | Q48326932 | ||
| Accumulation of microglial cells expressing ELR motif-positive CXC chemokines and their receptor CXCR2 in monkey hippocampus after ischemia-reperfusion. | Q48329599 | ||
| Promoted Interaction of C/EBPα with Demethylated Cxcr3 Gene Promoter Contributes to Neuropathic Pain in Mice | Q48338246 | ||
| Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma | Q48462130 | ||
| Differential regulation of the CXCR2 chemokine network in rat brain trauma: implications for neuroimmune interactions and neuronal survival | Q48653720 | ||
| Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
| Chemokine CCL2 up-regulated in the medullary dorsal horn astrocytes contributes to nocifensive behaviors induced by experimental tooth movement | Q48883778 | ||
| The effect of intrathecal administration of glial activation inhibitors on dorsal horn BDNF overexpression and hind paw mechanical allodynia in spinal nerve ligated rats | Q48911272 | ||
| Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. | Q50787458 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum. | Q51385140 | ||
| Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. | Q51432094 | ||
| An experimental model for chronic compression of dorsal root ganglion produced by intervertebral foramen stenosis in the rat. | Q51500141 | ||
| Up-regulation of interleukin-23 induces persistent allodynia via CX3CL1 and interleukin-18 signaling in the rat spinal cord after tetanic sciatic stimulation. | Q51764935 | ||
| Activation of spinal chemokine receptor CXCR3 mediates bone cancer pain through an Akt-ERK crosstalk pathway in rats. | Q51783352 | ||
| Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. | Q53548573 | ||
| Up-regulation of CX3CL1 via Nuclear Factor-κB-dependent Histone Acetylation Is Involved in Paclitaxel-induced Peripheral Neuropathy. | Q54181013 | ||
| CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats. | Q54309923 | ||
| CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. | Q54378064 | ||
| Expression of CCR2 in Both Resident and Bone Marrow-Derived Microglia Plays a Critical Role in Neuropathic Pain | Q56886107 | ||
| Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury | Q56886108 | ||
| Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice | Q57898584 | ||
| CC-chemokine MIP-1α in the spinal cord contributes to nerve injury-induced neuropathic pain | Q60688348 | ||
| Fractalkine--a strange attractor in the chemokine landscape | Q73308842 | ||
| Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage | Q74014533 | ||
| CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis | Q80880885 | ||
| Role for CXCR2 and CXCL1 on glia in multiple sclerosis | Q81020127 | ||
| Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses | Q81299416 | ||
| Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain | Q81919054 | ||
| Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis | Q83870435 | ||
| CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis | Q83918246 | ||
| Chemokine receptor antagonists | Q84893808 | ||
| Microglia and neuropathic pain | Q85946581 | ||
| The role of keratinocyte-derived chemokine (KC) on hyperalgesia caused by peripheral nerve injury in mice | Q86634610 | ||
| Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice | Q37084908 | ||
| Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development | Q37115195 | ||
| Spinal glial activation contributes to pathological pain states | Q37159943 | ||
| Glia in pathological pain: a role for fractalkine | Q37189198 | ||
| JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain | Q37194288 | ||
| Chemokines and pain mechanisms. | Q37215729 | ||
| Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour | Q37305415 | ||
| Chemokine network in the nervous system: a new target for pain relief. | Q37320292 | ||
| Chemokine receptor antagonists: overcoming developmental hurdles | Q37349685 | ||
| Cytokine and chemokine regulation of sensory neuron function. | Q37351994 | ||
| Glia and pain: is chronic pain a gliopathy? | Q37381399 | ||
| Chemokines and chemokine receptors: an overview. | Q37409994 | ||
| c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury? | Q37412516 | ||
| Chemokine receptor antagonists: Part 1. | Q37481238 | ||
| Chemokine receptor antagonists: part 2. | Q37481304 | ||
| Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons | Q37507494 | ||
| NFκB-mediated CXCL1 production in spinal cord astrocytes contributes to the maintenance of bone cancer pain in mice | Q37615222 | ||
| Chemokines, neuronal-glial interactions, and central processing of neuropathic pain | Q37684327 | ||
| CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord | Q37718182 | ||
| Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain | Q37726633 | ||
| Targeting astrocyte signaling for chronic pain | Q37794396 | ||
| Microglial signalling mechanisms: Cathepsin S and Fractalkine | Q37938541 | ||
| Chemokines and cytokines in neuroinflammation leading to neuropathic pain | Q37948466 | ||
| Chemokine mediated neuron-glia communication and aberrant signalling in neuropathic pain states | Q37953080 | ||
| Epigenetic regulation of spinal CXCR2 signaling in incisional hypersensitivity in mice | Q38113657 | ||
| Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4. | Q38196934 | ||
| Fractalkine/CX3CR1 signaling during neuropathic pain | Q38213379 | ||
| Neuronal CC chemokines: the distinct roles of CCL21 and CCL2 in neuropathic pain | Q38242192 | ||
| CCL2 is a key mediator of microglia activation in neuropathic pain states | Q38500555 | ||
| Crosstalk between astrocytic CXCL12 and microglial CXCR4 contributes to the development of neuropathic pain | Q38887975 | ||
| Chemokine CXCL13 activates p38 MAPK in the trigeminal ganglion after infraorbital nerve injury. | Q38982684 | ||
| Early Repeated Administration of CXCR4 Antagonist AMD3100 Dose-Dependently Improves Neuropathic Pain in Rats After L5 Spinal Nerve Ligation | Q39774997 | ||
| Expression, transport, and axonal sorting of neuronal CCL21 in large dense-core vesicles. | Q39951419 | ||
| Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine | Q40325740 | ||
| Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells | Q40805719 | ||
| The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. | Q41375167 | ||
| Upregulation of Chemokine CXCL12 in the Dorsal Root Ganglia and Spinal Cord Contributes to the Development and Maintenance of Neuropathic Pain Following Spared Nerve Injury in Rats | Q41465716 | ||
| Inhibition of reactive astrocytes with fluorocitrate retards neurovascular remodeling and recovery after focal cerebral ischemia in mice. | Q42256407 | ||
| P433 | issue | 18 | |
| P921 | main subject | neuropathic pain | Q2798704 |
| P304 | page(s) | 3275-3291 | |
| P577 | publication date | 2017-04-07 | |
| P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
| P1476 | title | Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain | |
| P478 | volume | 74 |
| Q92164639 | 2019 Academic Annual Meeting and the Frontier Seminar on "Glial Cell Function and Disease" (Nantong, China) |
| Q58786635 | An Integrative Approach to Neuroinflammation in Psychiatric disorders and Neuropathic Pain |
| Q48092684 | Analgesic Effect of Methane Rich Saline in a Rat Model of Chronic Inflammatory Pain. |
| Q58698333 | Analyses of gene expression profiles in the rat dorsal horn of the spinal cord using RNA sequencing in chronic constriction injury rats |
| Q89533456 | Bilateral activation of glial cells and cellular distribution of the chemokine CCL2 and its receptor CCR2 in the trigeminal subnucleus caudalis of trigeminal neuropathic pain model |
| Q95322235 | Biomolecular network-based synergistic drug combination discovery: a combination of paeoniflorin and liquiritin alleviates neuropathic pain by inhibiting neuroinflammation via suppressing the chemokine signaling pathway |
| Q52316849 | Bivalent ligand MCC22 potently attenuates nociception in a murine model of sickle cell disease. |
| Q90726399 | Brivaracetam attenuates pain behaviors in a murine model of neuropathic pain |
| Q92900028 | CXCL12/CXCR4 signaling contributes to neuropathic pain via central sensitization mechanisms in a rat spinal nerve ligation model |
| Q89545828 | Chemokine receptor CCR2 contributes to neuropathic pain and the associated depression via increasing NR2B-mediated currents in both D1 and D2 dopamine receptor-containing medium spiny neurons in the nucleus accumbens shell |
| Q98177456 | Chronic Pain After Spinal Cord Injury: Is There a Role for Neuron-Immune Dysregulation? |
| Q60921672 | Crosstalk between NFκB-dependent astrocytic CXCL1 and neuron CXCR2 plays a role in descending pain facilitation |
| Q92539077 | Cytokines in Pain: Harnessing Endogenous Anti-Inflammatory Signaling for Improved Pain Management |
| Q61449893 | Differential Gene Expression in Primary Cultured Sensory and Motor Nerve Fibroblasts |
| Q50426470 | Divergent roles of immune cells and their mediators in pain |
| Q64249807 | Dose-Dependent Effect of Hyperbaric Oxygen Treatment on Burn-Induced Neuropathic Pain in Rats |
| Q89207889 | E3 Ubiquitin Ligase c-cbl Inhibits Microglia Activation After Chronic Constriction Injury |
| Q94464662 | Electroacupuncture Treatment Suppresses Transcription Factor IRF8 in Spinal Cord of Rats with Spared Nerve Injury |
| Q57167233 | Exercise-Induced Changes to the Macrophage Response in the Dorsal Root Ganglia Prevent Neuropathic Pain after Spinal Cord Injury |
| Q93099253 | Induction of regional chemokine expression in response to human umbilical cord blood cell infusion in the neonatal mouse ischemia-reperfusion brain injury model |
| Q90354042 | Inhibition of chemokine CX3CL1 in spinal cord mediates the electroacupuncture-induced suppression of inflammatory pain |
| Q59352505 | Intercellular Communication Is Key for Protective IFNα/β Signaling During Viral Central Nervous System Infection |
| Q59350636 | Interferon regulatory factors 3 and 7 have distinct roles in the pathogenesis of alphavirus encephalomyelitis |
| Q64226464 | Investigation of Key Genes and Pathways in Inhibition of Oxycodone on Vincristine-Induced Microglia Activation by Using Bioinformatics Analysis |
| Q92559902 | Isotalatizidine, a C19-diterpenoid alkaloid, attenuates chronic neuropathic pain through stimulating ERK/CREB signaling pathway-mediated microglial dynorphin A expression |
| Q94544653 | Liquiritin Alleviates Pain Through Inhibiting CXCL1/CXCR2 Signaling Pathway in Bone Cancer Pain Rat |
| Q58588152 | Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study |
| Q90263532 | MC4R Is Involved in Neuropathic Pain by Regulating JNK Signaling Pathway After Chronic Constriction Injury |
| Q48256457 | Nociceptive Roles of TRPM2 Ion Channel in Pathologic Pain. |
| Q92546232 | Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors |
| Q91012595 | Role of macrophages and activated microglia in neuropathic pain associated with chronic progressive spinal cord compression |
| Q64079535 | Role of neuron and non-neuronal cell communication in persistent orofacial pain |
| Q55334164 | Spinal CXCL9 and CXCL11 are not involved in neuropathic pain despite an upregulation in the spinal cord following spinal nerve injury. |
| Q41429763 | Spinal cord injury drives chronic brain changes |
| Q89121908 | The Chemokine CCL4 (MIP-1β) Evokes Antinociceptive Effects in Mice: a Role for CD4+ Lymphocytes and Met-Enkephalin |
| Q47161248 | The Modulatory Properties of Chronic Antidepressant Drugs Treatment on the Brain Chemokine - Chemokine Receptor Network: A Molecular Study in an Animal Model of Depression |
| Q90069330 | The Secretomes of Painful Versus Nonpainful Human Schwannomatosis Tumor Cells Differentially Influence Sensory Neuron Gene Expression and Sensitivity |
| Q64119948 | Transcriptome profiling of dorsal root ganglia in a rat model of complex regional pain syndrome type-I reveals potential mechanisms involved in pain |
| Q92641580 | Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms |
| Q47219897 | Up-Regulation of CX3CL1 via STAT3 Contributes to SMIR-Induced Chronic Postsurgical Pain |
Search more.